Literature DB >> 24429291

Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni.

Xinying Jia1, Leigh Schulte, Alex Loukas, Darren Pickering, Mark Pearson, Mehdi Mobli, Alun Jones, Karl J Rosengren, Norelle L Daly, Geoffrey N Gobert, Malcolm K Jones, David J Craik, Jason Mulvenna.   

Abstract

The tetraspanins (TSPs) are a family of integral membrane proteins that are ubiquitously expressed at the surface of eukaryotic cells. TSPs mediate a range of processes at the surface of the plasma membrane by providing a scaffold for the assembly of protein complexes known as tetraspanin-enriched microdomains (TEMs). We report here the structure of the surface-exposed EC2 domain from Sm-TSP-2, a TSP from Schistosoma mansoni and one of the better prospects for the development of a vaccine against schistosomiasis. This is the first solution structure of this domain, and our investigations of its interactions with lipid micelles provide a general model for interactions between TSPs, membranes, and other proteins. Using chemical cross-linking, eight potential protein constituents of Sm-TSP-2-mediated TEMs were also identified. These include proteins important for membrane maintenance and repair, providing further evidence for the functional role of Sm-TSP-2- and Sm-TSP-2-mediated TEMs. The identification of calpain, Sm29, and fructose-bisphosphate aldolase, themselves potential vaccine antigens, suggests that the Sm-TSP-2-mediated TEMs could be disrupted via multiple targets. The identification of further Sm-TSP-2-mediated TEM proteins increases the available candidates for multiplex vaccines and/or novel drugs targeting TEMs in the schistosome tegument.

Entities:  

Keywords:  Membrane Proteins; Protein Structure; Proteomics; Schistosoma mansoni; Schistosomiasis; Tetraspanins; Vaccines

Mesh:

Substances:

Year:  2014        PMID: 24429291      PMCID: PMC3945375          DOI: 10.1074/jbc.M113.531558

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Proteins exposed at the adult schistosome surface revealed by biotinylation.

Authors:  Simon Braschi; R Alan Wilson
Journal:  Mol Cell Proteomics       Date:  2005-11-03       Impact factor: 5.911

2.  Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

Authors:  Heidi E Drummer; Kirilee A Wilson; Pantelis Poumbourios
Journal:  Biochem Biophys Res Commun       Date:  2005-03-04       Impact factor: 3.575

Review 3.  Tetraspanin functions and associated microdomains.

Authors:  Martin E Hemler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

4.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

5.  Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome.

Authors:  Bas W M van Balkom; Renske A van Gestel; Jos F H M Brouwers; Jeroen Krijgsveld; Aloysius G M Tielens; Albert J R Heck; Jaap J van Hellemond
Journal:  J Proteome Res       Date:  2005 May-Jun       Impact factor: 4.466

Review 6.  Gastrointestinal tumors: metastasis and tetraspanins.

Authors:  M Zöller
Journal:  Z Gastroenterol       Date:  2006-07       Impact factor: 2.000

7.  Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis.

Authors:  Mai H Tran; Mark S Pearson; Jeffrey M Bethony; Danielle J Smyth; Malcolm K Jones; Mary Duke; Tegan A Don; Donald P McManus; Rodrigo Correa-Oliveira; Alex Loukas
Journal:  Nat Med       Date:  2006-06-18       Impact factor: 53.440

8.  Requirement for annexin A1 in plasma membrane repair.

Authors:  Anna K McNeil; Ursula Rescher; Volker Gerke; Paul L McNeil
Journal:  J Biol Chem       Date:  2006-09-19       Impact factor: 5.157

9.  Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display.

Authors:  Yanchao Huang; Peter Verheesen; Andreas Roussis; Wendy Frankhuizen; Ieke Ginjaar; Faye Haldane; Steve Laval; Louise V B Anderson; Theo Verrips; Rune R Frants; Hans de Haard; Kate Bushby; Johan den Dunnen; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2005-06       Impact factor: 4.246

10.  The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans.

Authors:  Samuel Liégeois; Alexandre Benedetto; Jean-Marie Garnier; Yannick Schwab; Michel Labouesse
Journal:  J Cell Biol       Date:  2006-06-19       Impact factor: 10.539

View more
  12 in total

1.  Open conformation of tetraspanins shapes interaction partner networks on cell membranes.

Authors:  Yihu Yang; Xiaoran Roger Liu; Zev J Greenberg; Fengbo Zhou; Peng He; Lingling Fan; Shixuan Liu; Guomin Shen; Takeshi Egawa; Michael L Gross; Laura G Schuettpelz; Weikai Li
Journal:  EMBO J       Date:  2020-08-16       Impact factor: 11.598

2.  A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.

Authors:  W A Keitel; G E Potter; D Diemert; J Bethony; H M El Sahly; J K Kennedy; S M Patel; J L Plieskatt; W Jones; G Deye; M E Bottazzi; P J Hotez; R L Atmar
Journal:  Vaccine       Date:  2019-09-09       Impact factor: 3.641

3.  High Yield Expression of Recombinant CD151 in E. coli and a Structural Insight into Cholesterol Binding Domain.

Authors:  Gayathri Purushothaman; Vijay Thiruvenkatam
Journal:  Mol Biotechnol       Date:  2019-12       Impact factor: 2.695

Review 4.  Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.

Authors:  Chiuan Yee Leow; Charlene Willis; Andreas Hofmann; Malcolm K Jones
Journal:  Br J Pharmacol       Date:  2014-12-23       Impact factor: 8.739

Review 5.  The omic approach to parasitic trematode research-a review of techniques and developments within the past 5 years.

Authors:  Orçun Haçarız; Gearóid P Sayers
Journal:  Parasitol Res       Date:  2016-04-28       Impact factor: 2.289

6.  DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.

Authors:  Natan Raimundo Gonçalves de Assis; Suellen Batistoni de Morais; Bárbara Castro Pimentel Figueiredo; Natasha Delaqua Ricci; Leonardo Augusto de Almeida; Carina da Silva Pinheiro; Vicente de Paulo Martins; Sergio Costa Oliveira
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

7.  Exploring molecular variation in Schistosoma japonicum in China.

Authors:  Neil D Young; Kok-Gan Chan; Pasi K Korhonen; Teik Min Chong; Robson Ee; Namitha Mohandas; Anson V Koehler; Yan-Lue Lim; Andreas Hofmann; Aaron R Jex; Baozhen Qian; Neil B Chilton; Geoffrey N Gobert; Donald P McManus; Patrick Tan; Bonnie L Webster; David Rollinson; Robin B Gasser
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

8.  Suppression of mRNAs encoding CD63 family tetraspanins from the carcinogenic liver fluke Opisthorchis viverrini results in distinct tegument phenotypes.

Authors:  Sujittra Chaiyadet; Watchara Krueajampa; Wiphawi Hipkaeo; Yada Plosan; Supawadee Piratae; Javier Sotillo; Michael Smout; Banchob Sripa; Paul J Brindley; Alex Loukas; Thewarach Laha
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

9.  Functional characterisation of Schistosoma japonicum acetylcholinesterase.

Authors:  Hong You; Geoffrey N Gobert; Xiaofeng Du; Gabor Pali; Pengfei Cai; Malcolm K Jones; Donald P McManus
Journal:  Parasit Vectors       Date:  2016-06-10       Impact factor: 3.876

10.  Optimization of Expression and Purification of Schistosoma mansoni Antigens in Fusion with Rhizavidin.

Authors:  Mayra M F Barbosa; Alex I Kanno; Violeta Pancakova; Viviane M Gonçalves; Richard Malley; Leonardo P Faria; Luciana C C Leite
Journal:  Mol Biotechnol       Date:  2021-06-24       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.